PMC:7321036 / 41432-41844 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T335","span":{"begin":57,"end":61},"obj":"Body_part"},{"id":"T336","span":{"begin":280,"end":284},"obj":"Body_part"},{"id":"T337","span":{"begin":316,"end":320},"obj":"Body_part"}],"attributes":[{"id":"A335","pred":"fma_id","subj":"T335","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A336","pred":"fma_id","subj":"T336","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A337","pred":"fma_id","subj":"T337","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Figure S5 Pharmacological Profiling for Viral Titers and Cell Viability, Related to Figure 7\nDose response of phosphoproteomics-informed drugs and compounds. Assays performed in New York (N; red, anti-NP; blue TCID50) and Paris (P; red, RT-qPCR; purple, plaque assays) across two cell lines (A549-ACE2 and Vero E6). Cell viability shown in black. Mean of three biological replicates is shown. Error bars are SEM."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T471","span":{"begin":7,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0008933"},{"id":"T472","span":{"begin":57,"end":61},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T473","span":{"begin":201,"end":203},"obj":"http://purl.obolibrary.org/obo/CLO_0008192"},{"id":"T474","span":{"begin":280,"end":290},"obj":"http://purl.obolibrary.org/obo/CLO_0000031"},{"id":"T475","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0001601"},{"id":"T476","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0050025"},{"id":"T477","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0054264"},{"id":"T478","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0054265"},{"id":"T479","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0054266"},{"id":"T480","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0054267"},{"id":"T481","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0054268"},{"id":"T482","span":{"begin":292,"end":296},"obj":"http://purl.obolibrary.org/obo/CLO_0054269"},{"id":"T483","span":{"begin":306,"end":310},"obj":"http://purl.obolibrary.org/obo/CLO_0009524"},{"id":"T484","span":{"begin":306,"end":310},"obj":"http://purl.obolibrary.org/obo/CLO_0050515"},{"id":"T485","span":{"begin":316,"end":320},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Figure S5 Pharmacological Profiling for Viral Titers and Cell Viability, Related to Figure 7\nDose response of phosphoproteomics-informed drugs and compounds. Assays performed in New York (N; red, anti-NP; blue TCID50) and Paris (P; red, RT-qPCR; purple, plaque assays) across two cell lines (A549-ACE2 and Vero E6). Cell viability shown in black. Mean of three biological replicates is shown. Error bars are SEM."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T281","span":{"begin":7,"end":9},"obj":"Chemical"},{"id":"T282","span":{"begin":137,"end":142},"obj":"Chemical"},{"id":"T283","span":{"begin":201,"end":203},"obj":"Chemical"}],"attributes":[{"id":"A281","pred":"chebi_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/CHEBI_29386"},{"id":"A282","pred":"chebi_id","subj":"T282","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A283","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_50803"},{"id":"A284","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_53793"},{"id":"A285","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_73425"}],"text":"Figure S5 Pharmacological Profiling for Viral Titers and Cell Viability, Related to Figure 7\nDose response of phosphoproteomics-informed drugs and compounds. Assays performed in New York (N; red, anti-NP; blue TCID50) and Paris (P; red, RT-qPCR; purple, plaque assays) across two cell lines (A549-ACE2 and Vero E6). Cell viability shown in black. Mean of three biological replicates is shown. Error bars are SEM."}

{"project":"LitCovid-PubTator","denotations":[{"id":"793","span":{"begin":297,"end":301},"obj":"Gene"},{"id":"794","span":{"begin":292,"end":296},"obj":"CellLine"},{"id":"795","span":{"begin":311,"end":313},"obj":"CellLine"}],"attributes":[{"id":"A793","pred":"tao:has_database_id","subj":"793","obj":"Gene:103231639"},{"id":"A794","pred":"tao:has_database_id","subj":"794","obj":"CVCL:0023"},{"id":"A795","pred":"tao:has_database_id","subj":"795","obj":"CVCL:4582"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure S5 Pharmacological Profiling for Viral Titers and Cell Viability, Related to Figure 7\nDose response of phosphoproteomics-informed drugs and compounds. Assays performed in New York (N; red, anti-NP; blue TCID50) and Paris (P; red, RT-qPCR; purple, plaque assays) across two cell lines (A549-ACE2 and Vero E6). Cell viability shown in black. Mean of three biological replicates is shown. Error bars are SEM."}

{"project":"LitCovid-sentences","denotations":[{"id":"T269","span":{"begin":0,"end":92},"obj":"Sentence"},{"id":"T270","span":{"begin":93,"end":157},"obj":"Sentence"},{"id":"T271","span":{"begin":158,"end":315},"obj":"Sentence"},{"id":"T272","span":{"begin":316,"end":346},"obj":"Sentence"},{"id":"T273","span":{"begin":347,"end":392},"obj":"Sentence"},{"id":"T274","span":{"begin":393,"end":412},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure S5 Pharmacological Profiling for Viral Titers and Cell Viability, Related to Figure 7\nDose response of phosphoproteomics-informed drugs and compounds. Assays performed in New York (N; red, anti-NP; blue TCID50) and Paris (P; red, RT-qPCR; purple, plaque assays) across two cell lines (A549-ACE2 and Vero E6). Cell viability shown in black. Mean of three biological replicates is shown. Error bars are SEM."}